Skip to main content
Scroll Top
Menu
WHO WE ARE
ABOUT US
TEAM
MANAGEMENT TEAM
INDUSTRIAL ADVISORS
SCIENTIFIC COUNCIL
PARTNERS
R&D
INTRODUCTION
TECH
NEUROSTIMULATION
PHOTOBIOMODULATION
ALZHEIMER
CLINICAL TRIAL
PATHOPHYSIOLOGY
TECHNOLOGY
CONCUSSION
CLINICAL TRIAL
PATHOPHYSIOLOGY
TECHNOLOGY
SOLUTIONS
CLINICAL RESEARCH
PRECLINICAL RESEARCH
CONCUSSION
NEWS
ALL
PRESS ARTICLES
VIDEOS
EVENTS
SCIENTIFIC PUBLICATIONS
ALL
SCIENTIFIC ARTICLES
ORAL COMMUNICATIONS
POSTED COMMUNICATIONS
CONTACT
FAQ
Executive summary
Français
Menu
WHO WE ARE
ABOUT US
TEAM
MANAGEMENT TEAM
INDUSTRIAL ADVISORS
SCIENTIFIC COUNCIL
PARTNERS
R&D
INTRODUCTION
TECH
NEUROSTIMULATION
PHOTOBIOMODULATION
ALZHEIMER
CLINICAL TRIAL
PATHOPHYSIOLOGY
TECHNOLOGY
CONCUSSION
CLINICAL TRIAL
PATHOPHYSIOLOGY
TECHNOLOGY
SOLUTIONS
CLINICAL RESEARCH
PRECLINICAL RESEARCH
CONCUSSION
NEWS
ALL
PRESS ARTICLES
VIDEOS
EVENTS
SCIENTIFIC PUBLICATIONS
ALL
SCIENTIFIC ARTICLES
ORAL COMMUNICATIONS
POSTED COMMUNICATIONS
CONTACT
FAQ
Executive summary
Français
Home
Tag
17th edition of the Francophone Meetings on Alzheimer’s Disease and Related Syndromes (RFMASA) – Lausanne | 29 September to 1st October 2025
Past Events
6 March 2026
17th edition of the Francophone Meetings on Alzheimer’s Disease and Related Syndromes (RFMASA) – Lausanne | 29 September to 1st October 2025
Alzheimer’s disease: the promise of new Non-Invasive Brain Stimulation methods
Alzheimer
Posted Communications
5 March 2026
Alzheimer’s disease: the promise of new Non-Invasive Brain Stimulation methods
Neurointestinal stimulation: a new therapeutic approach for Alzheimer’s disease? News from the pivotal clinical trial LIGHT4LIFE
Alzheimer
Oral Communications
5 March 2026
Neurointestinal stimulation: a new therapeutic approach for Alzheimer’s disease? News from the pivotal clinical trial LIGHT4LIFE
Photobiomodulation Therapy: A Novel Therapeutic Approach to Alzheimer’s Disease Made Possible by the Evidence of a Brain-Gut Interconnection
Alzheimer
Scientific Articles
29 May 2024
Photobiomodulation Therapy: A Novel Therapeutic Approach to Alzheimer’s Disease Made Possible by the Evidence of a Brain-Gut Interconnection
Translation from Preclinical Research to Clinical Trials: Brain-Gut Photobiomodulation Therapy for Alzheimer’s Disease
Alzheimer
Scientific Articles
11 March 2024
Translation from Preclinical Research to Clinical Trials: Brain-Gut Photobiomodulation Therapy for Alzheimer’s Disease
Clinical Trials on Alzheimer’s Disease (CTAD CHINA)
Alzheimer
Oral Communications
24 October 2023
Clinical Trials on Alzheimer’s Disease (CTAD CHINA)
Challenges in developing Geroscience trials
Alzheimer
Scientific Articles
19 August 2023
Challenges in developing Geroscience trials
Does brain-gut photobiomodulation have therapeutic potential in Alzheimer’s Disease? Design of a pivotal sham-controlled, randomized, double-blind, multicentric clinical investigation
Alzheimer
Posted Communications
1 December 2022
Does brain-gut photobiomodulation have therapeutic potential in Alzheimer’s Disease? Design of a pivotal sham-controlled, randomized, double-blind, multicentric clinical investigation
A Randomized, Double-Blind, and Sham-Controlled Trial of an Innovative Brain-Gut Photobiomodulation Therapy: Safety and Patient Compliance
Alzheimer
Scientific Articles
1 November 2022
A Randomized, Double-Blind, and Sham-Controlled Trial of an Innovative Brain-Gut Photobiomodulation Therapy: Safety and Patient Compliance
15th International Conference on Alzheimer’s Disease & Parkinson’s disease (AD/PD) 2021, virtual conference
Alzheimer
Oral Communications
16 September 2021
15th International Conference on Alzheimer’s Disease & Parkinson’s disease (AD/PD) 2021, virtual conference
Photobiomodulation at the Level of Single Neural Cells in Culture
Alzheimer
Oral Communications
2 January 2021
Photobiomodulation at the Level of Single Neural Cells in Culture
Relevance of photobiomodulation technique in AD treatment
Alzheimer
Oral Communications
5 November 2020
Relevance of photobiomodulation technique in AD treatment
Prev
1
2
3
Next
Get a Quote
